Dr. Cortes Discusses Approval of Ponatinib for Adults with Chronic-phase CML DocWire 8:00 3 years ago 139 Далее Скачать
Dr. Cortes Discusses Ponatinib as Initial Therapy for CML OncLive 1:01 11 years ago 409 Далее Скачать
How to Treat Chronic Myeloid Leukemia (CML) - Dr. Jorge Cortes OncBrothers: Practice-Changing Cancer Discussions 26:14 4 months ago 2 468 Далее Скачать
FDA Approves New Dosing for Ponatinib to Treat Chronic Myeloid Leukemia CheckRare 6:39 3 years ago 418 Далее Скачать
Dr. Jorge Cortes Discusses the Ponatinib Ph+All and CML Evaluation (PACE) Trial OncLive 2:06 12 years ago 1 750 Далее Скачать
Dr. Cortes on Ponatinib in Patients with CML and Ph+ALL Targeted Oncology 1:56 12 years ago 459 Далее Скачать
Dr. Cortes Discusses the Use of Ponatinib in Types of Leukemia Targeted Oncology 1:12 11 years ago 268 Далее Скачать
Using ponatinib to treat highly resistant chronic myeloid leukemia, results from a Phase I trial VJHemOnc – Video Journal of Hematology & HemOnc 1:40 8 years ago 473 Далее Скачать
Ponatinib for CML and Ph+ ALL: five-year results from the PACE trial VJHemOnc – Video Journal of Hematology & HemOnc 1:16 1 year ago 471 Далее Скачать
Interim analysis from the OPTIC trial, a dose-ranging study of ponatinib for CP-CML ecancer 7:02 3 years ago 53 Далее Скачать
OPTIC: A dose-ranging study of 3 starting doses of ponatinib for chronic-phase chronic myeloid l... ecancer 6:16 4 years ago 61 Далее Скачать
Safety of ponatinib in chronic-phase chronic myeloid leukemia (CML) patients VJHemOnc – Video Journal of Hematology & HemOnc 1:35 7 years ago 394 Далее Скачать
An update on the OPTIC study: adjusting the dose of ponatinib for CP-CML VJHemOnc – Video Journal of Hematology & HemOnc 1:38 4 months ago 62 Далее Скачать
OPTIC: ponatinib in resistant chronic-phase CML VJHemOnc – Video Journal of Hematology & HemOnc 4:19 4 years ago 275 Далее Скачать
OPTIC: Ponatinib in chronic-phase CML VJHemOnc – Video Journal of Hematology & HemOnc 1:37 3 years ago 263 Далее Скачать
Ponatinib in chronic-phase CML patients with prior second generation TKI exposure VJHemOnc – Video Journal of Hematology & HemOnc 4:44 4 years ago 326 Далее Скачать
ASH 2021: New OPTIC Trial Analysis Shows Ponatinib is Effective in Chronic Myeloid Leukemia Patients CheckRare 3:31 3 years ago 398 Далее Скачать
Efficacy and safety of vodobatinib by lines of TKI therapy in Ph+ CML: a subgroup analysis VJHemOnc – Video Journal of Hematology & HemOnc 3:03 2 years ago 93 Далее Скачать
